Royal College of Surgeons in Ireland
Browse

Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis spectrum outcomes in early adulthood

Download (239.5 kB)
journal contribution
posted on 2024-11-11, 17:56 authored by David Mongan, Benjamin I Perry, Colm Healy, Subash Raji SusaiSubash Raji Susai, Stan Zammit, Mary CannonMary Cannon, David CotterDavid Cotter

Background: Evidence supports associations between polyunsaturated fatty acids such as docosahexaenoic acid (DHA) and psychosis. However, polyunsaturated fatty acid trajectories in the general population have not been characterized, and associations with psychosis spectrum outcomes in early adulthood are unknown.

Methods: Plasma omega-6 to omega-3 ratio and DHA (expressed as percentage of total fatty acids) were measured by nuclear magnetic spectroscopy at 7, 15, 17, and 24 years of age in participants of ALSPAC (Avon Longitudinal Study of Parents and Children). Curvilinear growth mixture modeling evaluated body mass index-adjusted trajectories of both measures. Outcomes were assessed at 24 years. Psychotic experiences (PEs), at-risk mental state status, psychotic disorder, and number of PEs were assessed using the Psychosis-Like Symptoms interview (n = 3635; 2247 [61.8%] female). Negative symptoms score was measured using the Community Assessment of Psychic Experiences (n = 3484; 2161 [62.0%] female). Associations were adjusted for sex, ethnicity, parental social class, and cumulative smoking and alcohol use.

Results: Relative to stable average, the persistently high omega-6 to omega-3 ratio trajectory was associated with increased odds of PEs and psychotic disorder, but attenuated on adjustment for covariates (PEs adjusted odds ratio [aOR] = 1.63, 95% CI = 0.92-2.89; psychotic disorder aOR = 1.69, 95% CI = 0.71-4.07). This was also the case for persistently low DHA (PEs aOR = 1.42, 95% CI = 0.84-2.37; psychotic disorder aOR = 1.14, 95% CI = 0.49-2.67). Following adjustment, persistently high omega-6 to omega-3 ratio was associated with increased number of PEs (β = 0.41, 95% CI = 0.05-0.78) and negative symptoms score (β = 0.43, 95% CI = 0.14-0.72), as was persistently low DHA (number of PEs β = 0.45, 95% CI = 0.14-0.76; negative symptoms β = 0.35, 95% CI = 0.12-0.58).

Conclusions: Optimization of polyunsaturated fatty acid status during development warrants further investigation in relation to psychotic symptoms in early adulthood.

Funding

Queen’s University Belfast and the Belfast Health and Social Care Trust Clinical Lectureship

University of Cambridge and Cambridgeshire

Peterborough National Health Service Foundation Trust Clinical Lectureship

Health Research Board Grant No. HRB ILP-PHR-2019-009 and Grant No. HRB/HRA/PHR/2015-1293

European Research Council Consolidator Award (iHEAR Grant No. 724809)

Wellcome Trust Innovations Award (Grant No. 220438Z/20/Z)

National Institute of Health and Care Research Biomedical Research Centre at University Hospitals Bristol

Weston National Health Service Foundation Trust

University of Bristol

Science Foundation Ireland (Grant No. 21/RC/10294_P2)

European Regional Development Fund

FutureNeuro industry partners

Medical Research Council (Grant No MC_UU_12013/1)

The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi- generation, longitudinal resource focusing on life course health and well- being.

Wellcome Trust

Find out more...

Pathways to psychosis: Investigating environmental, cognitive and genetic mechanisms underlying development of psychotic experiences in young adults

Medical Research Council

Find out more...

History

Comments

The original article is available at https://www.sciencedirect.com/

Published Citation

Mongan D. et al. Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis spectrum outcomes in early adulthood. Biol Psychiatry. 2024;96(10):772-781

Publication Date

15 April 2024

PubMed ID

38631425

Department/Unit

  • Beaumont Hospital
  • FutureNeuro Centre
  • Psychiatry

Publisher

Elsevier

Version

  • Published Version (Version of Record)